{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-027313","form_type":"8-K","ticker":"OMER","cik":"0001285819","company_name":"OMEROS CORP","filed_at":"2026-08-12T20:09:51+00:00","discovered_at":"2026-08-12T20:11:00.291705+00:00","generated_at":"2026-08-12T20:12:03.897497+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Omeros Q2: YARTEMLEA net rev $28.5M (+190% QoQ); adjusted EPS $0.02 vs -$0.24","bullets":["YARTEMLEA net revenue $28.5M in Q2 2026 (gross $32.2M), up 190% from Q1 gross $11.1M; gross-to-net ~11.5%.","GAAP net income $13.2M ($0.18/sh) vs $56.1M ($0.78) in Q1; non-GAAP adjusted net income $1.8M ($0.02) vs -$17.1M ($0.24).","Cash and short-term investments $132.0M at June 30, 2026; Q2 operating cash flow $4.1M.","In July, repurchased $30.5M principal of 2029 notes for $60.2M, cutting outstanding to $40.3M and conversion shares from ~11.4M to 6.5M.","CHMP negative opinion on narsoplimab MAA for TA-TMA in June; re-examination requested. J-code effective July 1, NTAP effective Oct 1."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-027313","json":"https://secwatch.observer/filing/0001437749-26-027313.json","markdown":"https://secwatch.observer/filing/0001437749-26-027313.md","text":"https://secwatch.observer/filing/0001437749-26-027313.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1285819/000143774926027313/0001437749-26-027313-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1285819/000143774926027313/omer20260521_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-12T20:12:03.897497+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}